Overactive Bladder

Characterizing the Health-Related Quality of Life Burden of Overactive Bladder Using Disease-Specific Patient-Reported Outcome Measures: A Systematic Literature Review. February 17, 2019

Predictors for De Novo Overactive Bladder after Readjustable Mid-Urethral Sling Procedure in Women with Stress Urinary Incontinence due to Intrinsic Sphincter Deficiency. February 17, 2019

Do Patients Discontinue Overactive Bladder Medications After Sacral Neuromodulation? February 10, 2019

Understanding overactive bladder and urgency incontinence: what does the brain have to do with it? February 10, 2019

Evaluation of real-world persistence of propiverine and trospium chloride in treatment of overactive bladder in Germany. February 3, 2019

Efficacy and safety of non-ablative vaginal erbium:YAG laser treatment as a novel surgical treatment for overactive bladder syndrome: comparison with anticholinergics and β3-adrenoceptor agonists. February 3, 2019

Overactive Bladder Symptoms After Pelvic Organ Prolapse Repair. February 3, 2019

Is the development of clinical practice guidelines for non-neurogenic overactive bladder trustworthy? A critical appraisal using the AGREE II instrument. January 27, 2019

The impact of Mirabegron on sexual function in women with idiopathic overactive bladder. January 27, 2019

Long-term treatment of older patients with overactive bladder using a combination of mirabegron and solifenacin: a prespecified analysis from the randomized, phase III SYNERGY II study. January 20, 2019

Overactive urinary bladder in elderly female patients: treatment specificities and drug interactions. January 20, 2019

Effectiveness and persistence of mirabegron as a first-line treatment in patients with overactive bladder in real-life practice. January 13, 2019

Prevalence, Risk Factors, and Treatment for Overactive Bladder in a Racially Diverse Population. January 6, 2019

Risk factors for persistent, de novo and overall overactive bladder syndrome after surgical prolapse repair. January 6, 2019

Mirabegron, alone and in combination, in the treatment of overactive bladder: real-world evidence and experience. December 30, 2018

Higher urge severity score predicts resumption of overactive bladder (OAB) medication following discontinuation of mirabegron treatment in patients with OAB. December 30, 2018

Factors influencing return for maintenance treatment with Percutaneous Tibial Nerve Stimulation for the management of the overactive bladder. December 30, 2018

Audiovisual stimulus during urodynamics to provoke detrusor overactivity: A randomized trial. December 23, 2018

Real-world persistence and adherence to oral antimuscarinics and mirabegron in patients with overactive bladder (OAB): a systematic literature review. December 23, 2018

FDA Approves Smart Programmer for the InterStim™ System December 17, 2018

Page 1 of 78

Pelvic Health Weekly Newsletter